Clinical Trial Update: Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and pharmacokinetics of inhaled ciprofloxacin in patients with mild to moderate chronic obstructive pulmonary disease has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: Bayer | Conditions: Disease, Pulmonary | Phase 1 | Status: COMPLETED